AR030554A1 - Moleculas similares a receptores il-17 y usos de las mismas - Google Patents

Moleculas similares a receptores il-17 y usos de las mismas

Info

Publication number
AR030554A1
AR030554A1 ARP010101203A ARP010101203A AR030554A1 AR 030554 A1 AR030554 A1 AR 030554A1 AR P010101203 A ARP010101203 A AR P010101203A AR P010101203 A ARP010101203 A AR P010101203A AR 030554 A1 AR030554 A1 AR 030554A1
Authority
AR
Argentina
Prior art keywords
receptors
same
similar molecules
polypeptides
methods
Prior art date
Application number
ARP010101203A
Other languages
English (en)
Spanish (es)
Inventor
Shuqian Jing
Eugene Medlock
Richard Yeh
Scott M Silbiger
Gary S Elliot
Hung Q Nguyen
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc filed Critical Amgen Inc
Publication of AR030554A1 publication Critical patent/AR030554A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7155—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
ARP010101203A 2000-03-16 2001-03-15 Moleculas similares a receptores il-17 y usos de las mismas AR030554A1 (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US18992300P 2000-03-16 2000-03-16
US20420800P 2000-05-12 2000-05-12
US72323200A 2000-11-27 2000-11-27
US26615901P 2001-02-02 2001-02-02

Publications (1)

Publication Number Publication Date
AR030554A1 true AR030554A1 (es) 2003-08-27

Family

ID=27497823

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP010101203A AR030554A1 (es) 2000-03-16 2001-03-15 Moleculas similares a receptores il-17 y usos de las mismas

Country Status (8)

Country Link
EP (1) EP1265924A2 (enrdf_load_stackoverflow)
JP (1) JP2003527117A (enrdf_load_stackoverflow)
AR (1) AR030554A1 (enrdf_load_stackoverflow)
AU (2) AU5902901A (enrdf_load_stackoverflow)
CA (1) CA2401273A1 (enrdf_load_stackoverflow)
MX (1) MXPA02009024A (enrdf_load_stackoverflow)
TW (1) TWI322154B (enrdf_load_stackoverflow)
WO (1) WO2001068705A2 (enrdf_load_stackoverflow)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7771719B1 (en) 2000-01-11 2010-08-10 Genentech, Inc. Pharmaceutical compositions, kits, and therapeutic uses of antagonist antibodies to IL-17E
IL138930A0 (en) 1998-05-15 2001-11-25 Genentech Inc Il-17 homologies polypeptides and therapeutic uses thereof
EP1897946B1 (en) * 1999-12-23 2012-07-11 Genentech, Inc. IL-17 homologous polypeptides and therapeutic uses thereof
US20040043397A1 (en) 2000-01-11 2004-03-04 Genentech, Inc. IL-17 homologous polypeptides and therapeutic uses thereof
US7718397B2 (en) 2000-03-21 2010-05-18 Genentech, Inc. Nucleic acids encoding receptor for IL-17 homologous polypeptides and uses thereof
US20030096969A1 (en) 2000-06-02 2003-05-22 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
AU2007202616B2 (en) * 2000-06-22 2011-08-18 Amgen Inc. IL-17 Like Molecules and Uses Thereof
EP1326626B1 (en) 2000-10-18 2020-04-01 Immunex Corporation Methods for treating rheumatoid arthritis using il-17 antagonists
WO2004013281A2 (en) * 2002-08-05 2004-02-12 Eli Lilly And Company Novel proteins and their uses
WO2004024076A2 (en) * 2002-09-11 2004-03-25 Genentech, Inc. Novel compositions and methods for the treatment of immune related diseases
AU2007235212A1 (en) * 2006-02-10 2007-10-18 Zymogenetics, Inc. Truncated IL-17RA soluble receptor and methods of using in inflammation
US7833527B2 (en) 2006-10-02 2010-11-16 Amgen Inc. Methods of treating psoriasis using IL-17 Receptor A antibodies
WO2008067057A2 (en) * 2006-10-13 2008-06-05 The Regents Of The University Of California Cancer treatment
WO2009069355A1 (ja) * 2007-11-28 2009-06-04 Riken Ｉｌ－１７ｒｂ陽性ｎｋｔ細胞を用いたアレルギー性気道炎症及び／又は気道過敏症の治療薬のスクリーニング方法
KR101508086B1 (ko) 2008-05-05 2015-04-07 노비뮨 에스 에이 항-ｉｌ-１７ａ／ｉｌ-１７ｆ 교차-반응성 항체 및 그의 사용 방법
GB0905972D0 (en) 2009-04-06 2009-05-20 Medical Res Council Antibodies against IL-17BR
KR101811886B1 (ko) 2009-05-05 2017-12-22 노비뮨 에스 에이 항―ｉｌ―17ｆ 항체 및 이의 사용 방법
NO2523688T3 (enrdf_load_stackoverflow) 2010-01-15 2018-03-10
AU2011235232B2 (en) * 2010-03-30 2015-05-21 Janssen Biotech Inc. Humanized IL-25 antibodies
EP2809660B1 (en) 2012-02-02 2016-01-20 Ensemble Therapeutics Corporation Macrocyclic compounds for modulating il-17

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL83878A (en) 1987-09-13 1995-07-31 Yeda Res & Dev Soluble protein corresponding to tnf inhibitory protein its preparation and pharmaceutical compositions containing it
US5106627A (en) 1987-11-17 1992-04-21 Brown University Research Foundation Neurological therapy devices
US4892538A (en) 1987-11-17 1990-01-09 Brown University Research Foundation In vivo delivery of neurotransmitters by implanted, encapsulated cells
US5319071A (en) 1987-11-25 1994-06-07 Immunex Corporation Soluble interleukin-1 receptors
US4968607A (en) 1987-11-25 1990-11-06 Immunex Corporation Interleukin-1 receptors
WO1989004838A1 (en) 1987-11-25 1989-06-01 Immunex Corporation Interleukin-1 receptors
US5011472A (en) 1988-09-06 1991-04-30 Brown University Research Foundation Implantable delivery system for biological factors
IL95031A (en) 1989-07-18 2007-03-08 Amgen Inc Method for the production of a human recombinant tumor necrosis factor inhibitor
US5350683A (en) 1990-06-05 1994-09-27 Immunex Corporation DNA encoding type II interleukin-1 receptors
DE69233441T2 (de) 1991-04-26 2005-10-13 Osaka Bioscience Institute, Suita Menschliches Zelloberflächen-Antigen codierende DNA
US5489743A (en) 1993-01-19 1996-02-06 Amgen Inc. Transgenic animal models for thrombocytopenia
EP0700435A1 (en) 1993-05-26 1996-03-13 Ontario Cancer Institute Transgenic mammals lacking expression of particular cd45 isoforms
US6664107B1 (en) 1993-05-26 2003-12-16 Ontario Cancer Institute, University Health Network CD45 disrupted nucleic acid
WO1995001997A1 (en) 1993-07-09 1995-01-19 Smithkline Beecham Corporation RECOMBINANT AND HUMANIZED IL-1β ANTIBODIES FOR TREATMENT OF IL-1 MEDIATED INFLAMMATORY DISORDERS IN MAN
CA2211038A1 (en) 1994-12-23 1996-07-04 Uab Research Foundation Secreted human fas antigen
KR19990022651A (ko) 1995-06-07 1999-03-25 데이비드 엘. 버스테인 생물학적 사건에 대한 라파마이신 기재 조절방법
DE69739853D1 (de) 1996-02-28 2010-06-02 Ariad Pharma Inc Synthetische rapamycinderivate als multimerisierende wirkstoffe für chimere proteine mit von immunophilin abgeleiteten domänen
EP1015488B1 (en) * 1997-09-17 2009-09-09 Human Genome Sciences, Inc. Interleukin-17 receptor-like protein
US6482923B1 (en) * 1997-09-17 2002-11-19 Human Genome Sciences, Inc. Interleukin 17-like receptor protein
WO1999035263A2 (en) * 1998-01-09 1999-07-15 Immunex Corporation Il-17rh dna and polypeptides
AU3207000A (en) * 1999-01-11 2000-08-01 Schering Corporation Interleukin-17 related mammalian cytokine (il-171). polynucleotides encoding them. uses
WO2000060080A2 (en) * 1999-04-05 2000-10-12 Incyte Pharmaceuticals, Inc. Molecules of the immune system
US7094886B2 (en) * 2000-02-04 2006-08-22 Board Of Trustees Of The University Of Arkansas Evi27 gene sequences and protein encoded thereby
WO2001059120A2 (en) * 2000-02-08 2001-08-16 Amgen, Inc. Il-17 like molecules and uses thereof
US9100155B2 (en) 2010-05-03 2015-08-04 Qualcomm Incorporated Method and apparatus for control and data multiplexing in wireless communication
JP6160461B2 (ja) 2013-11-29 2017-07-12 富士通株式会社 尤度重み付け回路

Also Published As

Publication number Publication date
AU5902901A (en) 2001-09-24
TWI322154B (en) 2010-03-21
WO2001068705A3 (en) 2002-07-18
AU2001259029B2 (en) 2006-01-05
MXPA02009024A (es) 2003-02-12
EP1265924A2 (en) 2002-12-18
CA2401273A1 (en) 2001-09-20
JP2003527117A (ja) 2003-09-16
WO2001068705A2 (en) 2001-09-20

Similar Documents

Publication Publication Date Title
AR030236A1 (es) Moléculas similares a il-17 y usos de las mismas
AR030554A1 (es) Moleculas similares a receptores il-17 y usos de las mismas
EP1363632A4 (en) SELECTIVE CANNABIMIMETIC AMINOALKYLINDOLES OF A RECEPTOR
DK1094816T3 (da) Biphenylsulfonamider som dobbelte angiotensin-endothelin-receptorantagonister
ECSP088508A (es) Antagonistas de neuropilina
NO20030374L (no) Syklopentanoindoler, preparater som inneholder slike forbindelser og behandlingsfremgangsmåter
BRPI0113286B8 (pt) pirazóis substituídos e composição farmacêutica compreendendo os mesmos.
DK0817770T3 (da) Nonpeptider som tachykininantagonister
EA200500520A1 (ru) Пуриновые соединения и их применение в качестве лигандов каннабиноидных рецепторов
HN2004000319A (es) "{ 1,8}naftiridin-2-onas y compuestos relacionados para el tratamiento de la esquizofrenia"
NO20010446L (no) Substituert anilidforbindelser og metoder
BR0208957A (pt) Ciclobuteno-1,2-dionas 3,4-dissubstituìdas como ligandos de receptor de quimiocina cxc
DE69942459D1 (de) Isolierte nukleinsäuremoleküle die t-zellen induzierbare faktoren kodieren (tif), kodierte proteine und ihre anwendung
TW200505875A (en) Novel compounds
HN2002000365A (es) Lactamas como antagonistas de taquiquininas
BR0114903A (pt) 7-azaindóis, sua aplicação como inibidores da fosfodiesterase 4 e processos para a sua preparação
WO2001068859A3 (en) Il-17 receptor like molecules and uses thereof
AR028579A1 (es) Metodo para el tratamiento de la sequedad vaginal, con agonistas del receptor de acetilcolina nicotinica
BRPI0409359A (pt) análogos quiméricos de somatostatina-dopamina
ECSP003707A (es) Diazepanes
ATE247130T1 (de) Inhibitoren für den urokinaserezeptor
ES2100051T3 (es) Sintesis de bloques dimeros y su uso en el ensamblaje de oligonucleotidos.
UY26265A1 (es) Compuestos calciolíticos
DK1455770T3 (da) Anvendelse af norepinephringenoptagelsesinhibitorer til behandling af tic lidelser
AR026767A1 (es) Moleculas similares a antagonistas de receptores de interleukin-1 y usos de las mismas

Legal Events

Date Code Title Description
FB Suspension of granting procedure